Viewing Study NCT05353257


Ignite Creation Date: 2025-12-24 @ 6:46 PM
Ignite Modification Date: 2025-12-25 @ 4:18 PM
Study NCT ID: NCT05353257
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-28
First Post: 2022-04-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module